Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Bone Remodeling01:40

Bone Remodeling

38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Disorders01:29

Bone Disorders

3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

4.5K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.5K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

2.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Evaluation of hiPSC-Derived Brain Organoids as Platforms for Assessing Thyroid Hormone System Disrupting Chemicals.

Cells·2026
Same author

[Metabolic bone disorders: what the internist must not overlook].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Increased fracture risk associated with iron-deficiency anemia: a population-based propensity score matched cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Pathophysiology, diagnosis and management of secondary osteoporosis.

Nature reviews. Endocrinology·2026
Same author

<i>Thra</i> knockout protects male mice from hyperthyroidism-driven cortical bone loss by mitigating bone resorption.

JBMR plus·2026

Related Experiment Video

Updated: Jun 26, 2025

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
06:59

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model

Published on: September 8, 2023

2.3K

Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts.

Franziska Lademann1, Eddy Rijntjes2, Josef Köhrle2

  • 1Department of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.

Communications Biology
|May 8, 2024
PubMed
Summary

Hyperthyroidism causes bone loss by increasing bone turnover. Blocking BMPR1A in osteoblasts, but not osteoclasts, prevents this osteoporosis by reducing bone resorption and thyroid hormone-induced activity.

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.2K
Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model
09:07

Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model

Published on: February 24, 2017

6.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
06:59

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model

Published on: September 8, 2023

2.3K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.2K
Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model
09:07

Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model

Published on: February 24, 2017

6.7K

Area of Science:

  • Endocrinology
  • Bone Biology
  • Cell Signaling

Background:

  • Hyperthyroidism elevates bone turnover, increasing osteoporosis risk.
  • Bone morphogenetic protein (BMP) signaling plays a role in bone metabolism.
  • Previous studies showed systemic BMPR1A blockade prevents hyperthyroid bone loss.

Purpose of the Study:

  • To investigate cell type-specific roles of BMPR1A in hyperthyroidism-induced osteoporosis.
  • To determine if BMPR1A deletion in osteoclasts or osteoprogenitors affects bone loss.
  • To elucidate the mechanism by which BMPR1A influences thyroid hormone effects on bone cells.

Main Methods:

  • Generated conditional knockout mice lacking Bmpr1a in osteoclast precursors (LysM-Cre) or osteoprogenitors (Osx-Cre).
  • Induced hyperthyroidism in knockout and wildtype mice.
  • Analyzed bone microarchitecture, strength, and turnover; performed in vitro studies on osteoblast and osteoclast activity.

Main Results:

  • Osteoclast-specific Bmpr1a deletion did not prevent hyperthyroidism-induced bone loss.
  • Osteoprogenitor-specific Bmpr1a deletion prevented increased bone resorption and osteoporosis.
  • Bmpr1a deletion in osteoblasts blocked thyroid hormone-induced differentiation, activity, and Rankl/Opg ratio changes.

Conclusions:

  • Osteoblastic BMPR1A is a key mediator of hyperthyroidism-induced osteoporosis.
  • BMPR1A in osteoblasts promotes thyroid hormone-driven osteoblast activity and coupling to osteoclast resorption.
  • Targeting osteoblastic BMPR1A may offer a therapeutic strategy for hyperthyroid osteoporosis.